Muscarinic M1 receptor agonists for pain management

Details for Australian Patent Application No. 2004226430 (hide)

Owner Acadia Pharmaceuticals Inc.

Inventors Rodriguez, Mario; Vanover, Kimberly; Davis, Robert R.

Agent Griffith Hack

Pub. Number AU-A-2004226430

PCT Pub. Number WO2004/087158

Priority 60/459,045 28.03.03 US

Filing date 26 March 2004

Wipo publication date 14 October 2004

International Classifications

A61K 031/454

A61K 031/538

A61P 029/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

3 November 2005 PCT application entered the National Phase

  PCT publication WO2004/087158 Priority application(s): WO2004/087158

21 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004226433-Oral hygiene apparatuses

2004226425-Energy based devices and methods for treatment of patent foramen ovale